StemCell Therapy

Dublin, April 09, 2020 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.

The global precision medicine market is estimated to grow at a CAGR of 9.8% during the forecast period. Factors such as the increasing prevalence of cancer, central nervous system disorder, and respiratory diseases coupled with the increasing focus on researches focusing on the development of precision medicine are augmenting the market growth. Moreover, the growing focus on the biomarkers is promising ample opportunities for the growth of the personalized medicine market across the globe.

The report analyzes the global precision medicine market on the basis of technology, application, end-use, and geography. On the basis of technology, the market is genomics, transcriptomics, and epigenomics. Based on the application, the market is classified into oncology, neurology, immunology, and others. Based on the end-user, the market is classified into pharmaceutical companies, diagnostic companies, and healthcare IT companies.

The advancement in genomic and clinical science have established advanced prospects to further customize healthcare to every patient. The Center for Individualized Medicine at Mayo Clinic is practicing personalized medicine and using it to the complete spectrum of healthcare with the use of sophisticated techniques of molecular analysis and genomic sequencing. Microbiome Program by Mayo Clinic enables to understand the cause of transmitting the infection through bacteria. It investigates several questions under the program, such as if microbial communities in the colon could be responsible for irritable bowel symptoms and gluten sensitivity. In addition, it examines the colon organisms affect other body parts, including the joints. The program explores the genetic code of the microorganism of the body. It uses advanced techniques for profiling the microbiome of an individual to detect, prevent and diagnose infections and other diseases. These rising focus of medical centers towards microbiome program for personalized medicine is expanding the scope for the growth of the global personalized medicine market.

Geographically, the market is analyzed into North America, Europe, Asia-Pacific, and the Rest of the World. North America is estimated to contribute a significant market share in the global precision medicine industry over the forecast period. Increasing prevalence of cancer, respiratory diseases, and neurological disorders are augmenting the growth of the North America precision medicine market. Moreover, the presence of prominent institutes and market players focusing on the development of precision medicine through researches are also driving the market growth of the region.

Furthermore, the market is characterized by the presence of several players including F. Hoffmann La Roche Ltd., Abbott Laboratories Inc., Pfizer Inc., Qiagen NV, Teva Pharmaceutical Industries Ltd., Eagle Genomics, and many others. These players adopt various strategies to capitalize on market growth opportunities. For instance, in October 2018, Eagle Genomics partnered with Microsoft Genomics to tackle the computational challenges of the genomics era. The aim of the partnership was to introduce the scale and power of the cloud to precision medicine, across the production of fundamental research and core services.

The Report Covers:

Key Topics Covered:

1. Report Summary1.1. Research Methods and Tools1.2. Market Breakdown1.2.1. By Segments1.2.2. By Geography

2. Market Overview and Insights2.1. Scope of the Report 2.2. Analyst Insight & Current Market Trends2.2.1. Key Findings2.2.2. Recommendations2.2.3. Conclusion2.3. Rules & Regulations

3. Competitive Landscape3.1. Company Share Analysis3.2. Key Strategy Analysis3.3. Key Company Analysis3.3.1. F. Hoffmann La Roche Ltd.3.3.1.1. Overview3.3.1.2. Financial Analysis3.3.1.3. SWOT Analysis3.3.1.4. Recent Developments3.3.2. Abbott Laboratories Inc.3.3.2.1. Overview3.3.2.2. Financial Analysis3.3.2.3. SWOT Analysis3.3.2.4. Recent Developments3.3.3. Pfizer Inc.3.3.3.1. Overview3.3.3.2. Financial Analysis3.3.3.3. SWOT Analysis3.3.3.4. Recent Developments3.3.4. Qiagen NV3.3.4.1. Overview3.3.4.2. Financial Analysis3.3.4.3. SWOT Analysis3.3.4.4. Recent Developments3.3.5. Teva Pharmaceutical Industries Ltd. 3.3.5.1. Overview3.3.5.2. Financial Analysis3.3.5.3. SWOT Analysis3.3.5.4. Recent Developments

4. Market Determinants4.1. Motivators4.2. Restraints4.3. Opportunities

5. Market Segmentation5.1. Global Precision Medicine Market by Technology 5.1.1. Genomics5.1.2. Transcriptomics5.1.3. Epigenomics5.2. Global Precision Medicine Market by Application5.2.1. Oncology5.2.2. Neurology 5.2.3. Immunology5.2.4. Others (Respiratory)5.3. Global Precision Medicine Market by End-Use5.3.1. Pharmaceutical Companies5.3.2. Diagnostic Companies5.3.3. Healthcare IT Companies

6. Regional Analysis6.1. North America6.1.1. United States6.1.2. Canada6.2. Europe6.2.1. UK6.2.2. Germany6.2.3. Italy6.2.4. Spain6.2.5. France6.2.6. Rest of Europe6.3. Asia-Pacific6.3.1. China6.3.2. Japan6.3.3. India6.3.4. Rest of Asia-Pacific6.4. Rest of the World

7. Company Profiles

Companies Mentioned

Story continues

For more information about this report visit https://www.researchandmarkets.com/r/kdkbgk

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Originally posted here:
Outlook on the Worldwide Precision Medicine Industry to 2025 - Growing Focus on Biomarkers is Promising Ample Opportunities - Yahoo Finance

This entry was posted on April 10, 2020 at 2:46 pm and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |